
SGRY Stock Analysis
Surgery Partners Inc
HEALTHCARE
MEDICAL CARE FACILITIES
Performance Overview
Trailing adjusted-close returns as of 2026-07-27. Benchmark is SPY.
YTD Return
1-Year Return
3-Year Return
5-Year Return
Returns are calculated from adjusted close prices and may differ from broker or research-site totals depending on data source, dividend handling, benchmark choice, and latest available trading date.
Legacy Screening Checks
This page uses cached SQL data from the latest StockValueFinder scan, so it loads fast without hitting Alpha Vantage on every page view.
Looks for positive and improving earnings per share.
Looks for strong return on invested capital.
Checks whether operating income comfortably covers interest expense.
Checks whether free cash flow could pay down long-term debt quickly.
Checks whether valuation is reasonable under the current rule set.
Uses 20-day, 50-day, and 200-day moving averages for entry timing context.
Cached Technical Data
Moving average values from the latest stored scan.
Latest Published Stock Research
Research generated: October 23, 2026
SGRY Stock Analysis: Why Surgery Partners Inc Scored 10% in Stock Value Finder
Analyzing Surgery Partners Inc (SGRY): A Comprehensive StockValueFinder Educational Review
This research article provides a detailed educational breakdown of Surgery Partners Inc (SGRY), operating within the Healthcare sector and specifically the Medical Care Facilities industry. This is a complete educational StockValueFinder review designed to teach investors how to interpret specific financial metrics and understand the mechanics of fundamental analysis. The goal of this report is not to provide a recommendation, but to demonstrate how quantitative screens are applied to evaluate the quality and risk profile of a company.
Overview of Surgery Partners Inc (SGRY)
Surgery Partners Inc (SGRY) operates in the medical care facilities industry. In the broader context of healthcare, companies in this sector often manage outpatient surgery centers and related medical services. When evaluating such companies, an analyst must look beyond the service provided and focus heavily on the underlying financial architecture: how much debt they carry, how efficiently they use their capital, and whether their earnings can support their valuation.
In an era of fluctuating interest rates and increasing government debt, the stability of a company's balance sheet is paramount. For an investor focused on preserving purchasing power, the ability of a company to generate real returns without being crushed by debt service is a critical component of long-term survival.
Why the StockValueFinder Score Matters
Every company analyzed by our system receives a StockValueFinder score. For Surgery Partners Inc, the current score is 10%. Based on this quantitative assessment, the rating for SGRY is AVOID.
It is important to understand what a score represents. The StockValueFinder score is a composite metric that aggregates various tests, including valuation, profitability, debt management, and earnings consistency. A low score, such as 10%, indicates that the company has failed multiple critical screens designed to identify high-quality, value-oriented businesses. A high score would suggest a company that meets stringent criteria for profitability and financial safety. In this case, the low score serves as a warning sign that the company’s current financial profile does not align with conservative, disciplined investment principles.
EPS Strength and Consistency
Earnings Per Share (EPS) is a fundamental metric representing the portion of a company's profit allocated to each outstanding share of common stock. Consistency in EPS is vital because it demonstrates a company's ability to generate predictable profits over time, which is essential for navigating economic cycles and inflationary pressures.
In the case of Surgery Partners Inc, the system recorded an EPS test result of "Did not pass." While the specific historical EPS values were not supplied in this data set, a failure in this category indicates that the company has not met the required threshold for earnings stability or growth as defined by our screening criteria.
**Educational Example:** To evaluate other stocks, look for a history of steady or growing EPS. For instance, if Company A earns $1.00 per share every year for five years, it shows stability. If Company B earns $5.00 one year but loses $2.00 the next, it shows high volatility. Investors seeking to avoid uncertainty generally prefer the predictability of Company A over the volatility of Company B.
ROIC and Capital Efficiency
Return on Invested Capital (ROIC) is one of the most important metrics for assessing how effectively a management team uses the money it has raised (through both debt and equity) to generate profits. It measures the efficiency of a company's capital allocation.
Surgery Partners Inc reports an ROIC of -1.36%.
The StockValueFinder system generally prefers an ROIC of 10% or higher. A positive ROIC indicates that the company is creating value; a negative ROIC, as seen with SGRY, means the company is actually destroying capital by earning less than the cost of the funds used to operate.
**Educational Example:** Consider two different companies. Company X has an ROIC of 15%, meaning for every dollar invested, it generates 15 cents in profit. Company Y has an ROIC of 4%. Even if both companies are profitable, Company X is significantly more efficient at using its capital to grow. A negative ROIC, like the -1.36% seen in SGRY, suggests a much higher level of operational inefficiency and risk to shareholders.
Interest Coverage and Financial Safety
Interest coverage is a solvency ratio that measures how easily a company can pay the interest expenses on its outstanding debt. This is a critical metric in a high-interest-rate environment, as rising rates can increase the cost of servicing debt and squeeze profit margins.
The system recorded that Surgery Partners Inc "Did not pass" the interest coverage test. StockValueFinder prefers an interest coverage ratio of 6 or higher to ensure a significant safety buffer.
**Educational Example:** If a company has an interest coverage ratio of 8x, it means its earnings are eight times larger than its interest obligations. This provides a large cushion if earnings temporarily dip. If a company has an interest coverage ratio of 2x, it only has twice as much earnings as it needs to pay its interest. This is considered a weak or risky range because even a small decline in earnings could leave the company unable to meet its debt obligations.
Debt Payback and Balance Sheet Discipline
Debt payback (often expressed as the number of years of earnings required to pay off total debt) measures the long-term sustainability of a company's leverage. It tells us how much time it would take for a company to clear its debt if all current earnings were dedicated to that purpose.
Surgery Partners Inc has a debt payback period of 18.42 years.
The StockValueFinder system prefers a debt payback period of 3 years or less. A period of 18.42 years is exceptionally high, suggesting that the company is heavily leveraged and may struggle to deleverage in a volatile economic environment. High debt levels increase the risk of insolvency if cash flows are interrupted by inflation, recession, or changes in healthcare regulations.
**Educational Example:** A company with a debt payback of 1.5 years is in an extremely strong position, as it can clear its obligations very quickly. A company with a debt payback of 7 years is more heavily burdened but may still be manageable depending on growth. However, a company with 18.42 years of debt—like SGRY—is carrying a burden that could take nearly two decades to resolve under current earnings levels, representing significant long-term uncertainty.
P/E Ratio and Valuation Discipline
The Price-to-Earnings (P/E) ratio is a valuation metric that compares the current share price to its per-share earnings. It helps investors determine if they are paying a premium or receiving a discount for the company's profits.
Surgery Partners Inc has a P/E ratio of 34.24.
For maintaining valuation discipline, StockValueFinder prefers a P/E ratio of 15 or lower. A P/E of 34.24 indicates that the market is pricing the stock at a significant premium relative to its current earnings. When combined with the failed EPS and ROIC tests, this high P/E suggests that the stock may be overvalued relative to its actual financial performance.
**Educational Example:** If Company A has a P/E of 8, an investor is paying $8 for every $1 of earnings. If Company B has a P/E of 40, the investor is paying $40 for every $1 of earnings. Assuming the business quality is sound, a P/E of 8 is considered more value-oriented, whereas a P/E of 40 requires the investor to believe that massive growth is imminent to justify the high price.
Moving Average Trend and Entry Timing
While fundamental analysis looks at the "what" and "why" of a company, technical indicators like moving averages are used to understand market sentiment and timing.
The current moving average signal for SGRY is NEUTRAL / WATCH. Additionally, the entry signal is N/A.
Moving averages are used for timing discipline; they help identify whether a stock is in an uptrend, a downtrend, or moving sideways. A "Neutral/Watch" signal suggests there is no clear directional momentum currently driving the stock, meaning it is neither in a strong bullish trend nor a confirmed bearish collapse. It is important to note that a moving average signal is not proof that a stock must rise or fall; it is merely a tool to observe recent price trends.
Regarding specific entry points
These fields are intended to provide educational reference levels for where an investor might look for entry or exit points based on price action. Since no data was supplied, these remain N/A for SGRY.
Overall Financial Strengths and Weaknesses
Based on the data provided, Surgery Partners Inc (SGRY) presents a profile characterized by significant financial headwinds.
**Strengths:** The current data does not highlight any specific fundamental strengths in the categories of profitability, debt management, or valuation. The only available data point is the current price of $15.75 and a neutral moving average signal, which indicates a lack of immediate trend volatility.
**Weaknesses:**
The weaknesses are extensive and systemic across the analyzed metrics
1. **Profitability:** The ROIC is negative (-1.36%), indicating capital destruction. 2. **Valuation:** The P/E ratio (34.24) is significantly higher than the preferred threshold of 15, suggesting high cost for current earnings. 3. **Solvency:** The company failed the interest coverage test and carries a massive debt payback period of 18.42 years. 4. **Earnings:** The company failed the EPS strength test, indicating a lack of consistent earnings history.
Risks and Limitations
Investing in companies with high debt-to-earnings ratios and negative ROIC involves substantial risk. In an environment where the cost of capital can rise due to central bank policies, companies with 18.42 years of debt payback are particularly vulnerable to interest rate shocks. Furthermore, because the P/E is high despite poor earnings performance, there is a significant risk of "multiple contraction," where the stock price falls even if earnings remain flat, simply because investors are no longer willing to pay a premium for those earnings.
Investors must also recognize the limitations of this analysis. This report is based on specific, supplied quantitative metrics. It does not account for qualitative factors such as changes in healthcare legislation, management shifts, or sudden market disruptions that are not captured in historical financial statements.
Educational Conclusion
Through this review of Surgery Partners Inc (SGRY), we have applied a disciplined, hard-money approach to stock analysis. By examining ROIC, interest coverage, debt payback, and P/E ratios, we can move beyond surface-level price movements to see the actual health of a business.
In this case, SGRY failed nearly every major quantitative test designed to identify stable, value-oriented companies. The combination of negative capital efficiency (ROIC), high debt obligations (Debt Payback), and expensive valuation (P/E) resulted in a StockValueFinder score of 10% and an AVOID rating. This exercise demonstrates how systematic screening can help an investor identify companies that may pose significant risks to capital preservation.
This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.
Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings
30-Day Trendline Analysis
Optional intraday chart with rising support, falling resistance, and multi-timeframe views.